Amphotericin B in visceral leishmaniasis.
Jha
B B
BB
D000666:Amphotericin B / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D010419:Pentamidine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D010419:Pentamidine; D000666:Amphotericin B; D000967:Antimony Sodium Gluconate